Fitbit-Tracked Micromovement for Cardiometabolic Risk Factors
(RISE-W Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This pilot study tests whether a low-burden prevention program can be integrated into routine care to identify and reduce cardiometabolic risk in rural women. Rural women face high rates of cardiometabolic syndrome, a cluster of conditions (elevated blood pressure, abdominal obesity, abnormal cholesterol, and high blood sugar) that raises the risk of heart disease and diabetes, yet often face barriers to prevention and screening.
The study enrolls physically inactive adult women with multiple cardiometabolic risk factors who receive care at a rural federally qualified health center. At a baseline visit, participants complete surveys and clinical assessments including inflammatory biomarkers (C-reactive protein and interleukin-6), metabolic labs, blood pressure, waist circumference, menopausal status, and social determinants of health. Participants then take part in a 12-week program of brief, frequent daily movement supported by a wearable activity tracker. Assessments are repeated at 12 weeks.
Because this is a single-group pilot, every participant receives the program and serves as her own comparison. The study evaluates whether the model is feasible to run within routine clinic workflows and examines preliminary changes in cardiometabolic and inflammatory risk indicators. Findings will inform larger studies of scalable prevention strategies for rural women.
Who Is on the Research Team?
Jeni Page, PhD, APRN, ACNP-BC
Principal Investigator
Texas Tech University Health Sciences Center
Are You a Good Fit for This Trial?
This trial is for adult women living in rural areas who are physically inactive and have several risk factors for heart disease or diabetes, such as high blood pressure, large waist size, abnormal cholesterol, or high blood sugar. Participants must receive care at a rural health center.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- RISE-W Micro-Movement Program
Trial Overview
The study tests a 12-week program where participants use a wearable activity tracker (like a Fitbit) to encourage brief daily movement. All participants get the same program and their health markers are checked before and after the program.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants receive the 12-week RISE-W micro-movement prevention program: brief bouts of light-to-moderate movement each waking hour (target ≥10 hours/day), supported by a wearable activity tracker that provides hourly movement reminders and enables self-monitoring.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Texas Tech University Health Sciences Center
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.